These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9237182)
1. Key features distinguishing post-transplantation lymphoproliferative disorders and acute liver rejection. Rizkalla KS; Asfar SK; McLean CA; Garcia BM; Wall WJ; Grant DR Mod Pathol; 1997 Jul; 10(7):708-15. PubMed ID: 9237182 [TBL] [Abstract][Full Text] [Related]
2. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder. Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104 [TBL] [Abstract][Full Text] [Related]
3. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients. Rosendale B; Yousem SA Arch Pathol Lab Med; 1995 May; 119(5):418-23. PubMed ID: 7748068 [TBL] [Abstract][Full Text] [Related]
4. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965 [TBL] [Abstract][Full Text] [Related]
5. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198 [TBL] [Abstract][Full Text] [Related]
6. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients. Shapiro NL; Tang CG; Bhattacharyya N Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960 [TBL] [Abstract][Full Text] [Related]
7. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Lones MA; Shintaku IP; Weiss LM; Thung SN; Nichols WS; Geller SA Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700 [TBL] [Abstract][Full Text] [Related]
8. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010 [TBL] [Abstract][Full Text] [Related]
9. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109 [TBL] [Abstract][Full Text] [Related]
11. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438 [TBL] [Abstract][Full Text] [Related]
12. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Johnson LR; Nalesnik MA; Swerdlow SH Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation. Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136 [TBL] [Abstract][Full Text] [Related]
14. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD. D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402 [TBL] [Abstract][Full Text] [Related]
15. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases. Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262 [TBL] [Abstract][Full Text] [Related]
16. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A. Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692 [TBL] [Abstract][Full Text] [Related]
18. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children. Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323 [TBL] [Abstract][Full Text] [Related]
19. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler. Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933 [TBL] [Abstract][Full Text] [Related]
20. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]